The prevalence of rare genetic disorders (RGDs) in India — home to about 90 million RGD-affected people — has redrawn the extent of ‘rareness’ associated with these diseases.
Inadequate early-diagnosis systems and staggeringly high treatment costs make RGD a complex challenge. Tata Institute for Genetics and Society (TIGS) is partnering with the Centre for DNA Fingerprinting and Diagnostics (CDFD) Hyderabad, to develop cost-effective RGD diagnostics, screening and treatment. CDFD, a Centre Of Excellence (COE) for rare diseases, is funded by the Department of Biotechnology, under the Ministry of Science and Technology.
The MoU Was signed by Dr. Rakesh Mishra, Director TIGS and Dr. Thangaraj K, Director, DBT – CDFD in presence of other scientists from both institutes.
Read more about the event covered by Deccan Herald here
